Skip To Main Content

Global Developments in Early Detection
of Autoimmune Type 1 Diabetes

Curious about the characteristics of pre-symptomatic- and stage 3 Type 1 Diabetes? Interested in learning about the potential benefits of screening for autoimmune Type 1 Diabetes?

This short film gives you an overview of recent developments in diagnosis of Type 1 Diabetes, showcasing how early detection efforts can benefit those who need it the most.

Type 1 Diabetes (T1D) is an autoimmune condition which occurs when the immune system accidentally attacks the insulin-producing beta cells in the pancreas.1 The immune system’s attack leads to a progressive decline in beta cell function and leads the body to produce less insulin.2,3

Autoimmune T1D progresses in 3 stages where the first two stages are pre-symptomatic.3-6

The autoimmunity and the progressive decline in functional beta cell mass often begin months to years before the onset of more commonly known symptoms of Type 1 Diabetes.3-6

Autoimmune T1D may present with preventable life-threatening complications, such as diabetic ketoacidosis, which can lead to hospitalization and leave a severe psychological impact.7-11

Early detection of autoimmune T1D may positively affect longevity and decreases morbidity.

Early detection may also have a significant impact on the quality of life and mental health of those who are diagnosed and their families.12-17

Proactive testing for diabetes-specific autoantibodies can transform lives by detecting autoimmune T1D before symptoms develop.18-19

Referencer

MAT-BE-2400990–v1.0–OCT/2024